New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
16:10 EDTCFNCareFusion sees FY13 EPS $2.11-$2.21, consensus $2.15
Sees FY13 revenue up 1%-3% vs. FY12 revenue of $3.6B, consensus $3.65B.
News For CFN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent CFN news | >>
October 15, 2014
07:32 EDTCFNUBM Canon to hold a conference
PLASTEC Midwest Conference is being held in Chicago on October 15-16.
October 13, 2014
07:25 EDTCFNEuropean Association of Cardiothoracic Surgery to hold annual meeting
28th EACTS Annual Meeting is being held in Milan, Italy on October 11-15.
October 8, 2014
16:55 EDTCFNCareFusion, Netsmart announce enhanced medication dispensing collaboration
Netsmart and CareFusion announced an agreement to bring enhanced medication dispensing and management capabilities to behavioral health care provider organizations nationwide. The two companies will collaborate to integrate the medication use expertise of CareFusion with the closed-loop medication management capabilities of Netsmart, while re-defining interoperability within the non-acute health care industry. The collaboration will help ensure behavioral health patients, the Intellectual and Developmental Disabilities community and those receiving residential services will benefit from innovative, advanced medication dispensing and management solutions for the specific needs of lower-acuity markets.
07:18 EDTCFNInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
October 7, 2014
10:02 EDTCFNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:08 EDTCFNCareFusion downgraded to Market Perform from Outperform at BMO Capital
Subscribe for More Information
06:23 EDTCFNCareFusion downgraded to Neutral from Overweight at JPMorgan
Subscribe for More Information
05:37 EDTCFNBecton Dickinson upgraded to Buy from Hold at Stifel
Stifel upgraded Becton Dickinson (BDX) to Buy with a $153 price target citing significant accretion from the takeover of CareFusion (CFN).
October 6, 2014
17:09 EDTCFNBecton Dickinson acquisition of CareFusion will benefit investors, Barron's says
Subscribe for More Information
16:20 EDTCFNOn The Fly: Closing Wrap
Stocks on Wall Street opened in positive territory and appeared ready to ride the wave of optimism from Friday’s jobs report into the new week. However, with little on the economic calendar to sustain the momentum, each of the major equity indexes had given up their gains by noon. The Dow and S&P 500 made it back to flat late in the session, but weakened into the close to end the day slightly lower. The tech-heavy Nasdaq was the laggard throughout and ended the day with the most significant decline. ECONOMIC EVENTS: In the U.S., no major economic data was reported. COMPANY NEWS: Hewlett-Packard (HPQ) climbed $1.67, or 4.74%, to $36.87 after it confirmed plans to split itself into two publicly traded companies by the end of its fiscal 2015. One company will include HP's technology infrastructure, software and services businesses, to be known as "Hewlett-Packard Enterprise," while the other will include the company's PC and printing businesses and be called "HP Inc." After the announcement, HP shares were upgraded to Outperform from Neutral at Credit Suisse, while analysts at Cantor called the split "a bold and smart move" that will give HP the financial flexibility needed to sell off one or both of the PC and printing businesses if an attractive offer emerges for either or both. MAJOR MOVERS: Among the notable gainers was Durata Therapeutics (DRTX), which surged $10.36, or 74.64%, to $24.24 after the company agreed to be acquired by larger drugmaker Actavis (ACT) for $23.00 per share in cash, or approximately $675M, and contingent value rights for additional cash payments of up to $5.00 per share if certain regulatory or commercial milestones related to Durata's lead product are achieved. Also higher was CareFusion (CFN), which jumped $10.58, or 22.92%, to $56.75 after agreeing to be acquired by Becton Dickinson (BDX) for $49 in cash and 0.0777 of a share of BD for each share of CareFusion, or about $12.2B. Becton Dickinson rose $9.14, or 7.89%, to $124.98 after its deal, while Actavis slipped $2.12, or 0.86%, to $243.95, after its own, much smaller purchase. GT Advanced Technologies (GTAT) plunged $10.22, or 92.46%, to 83c after the company announced that it and some of its units had commenced voluntary cases under chapter 11 of the bankruptcy code, which Raymond James believes implies a "fundamental, severe breakdown" of the company's relationship with Apple (AAPL). Also lower were shares of Sunesis (SNSS), which dropped $5.18, or 78.01%, to $1.46 and was downgraded at RBC Capital and Wells Fargo after a trial of a combination therapy for patients with first relapsed or refractory acute myeloid leukemia did not meet its primary endpoint. INDEXES: The Dow slid 17.78, or 0.1%, to 16,991.91, the Nasdaq fell 20.82, or 0.47%, to 4,454.80, and the S&P 500 slipped 3.08, or 0.16%, to 1,964.82.
14:26 EDTCFNCareFusion downgraded to Neutral from Overweight at Piper Jaffray
Subscribe for More Information
12:41 EDTCFNOn The Fly: Midday Wrap
Subscribe for More Information
11:16 EDTCFNBecton Dickinson agrees to buy CareFusion for $12.2B, shares rise
Subscribe for More Information
10:18 EDTCFNBecton Dickinson price target raised to $141 from $127 at Piper Jaffray
Subscribe for More Information
08:23 EDTCFNBD says will have presence in nearly every country after CareFusion deal
Becton Dickinson (BDX) says that its acquisition of CareFusion (CFN) creates a "stronger" platform for diversified growth for the company. Says will leverage BD's "strong" international presence to accelerate growth of CareFusion products. Says the deal is consistent with BD's long-term revenue growth aspirations. Says emerging markets are a "key" growth driver for BD. Says will move to cash earnings going forward. Says expected revenue growth synergies from the deal have not been taken to account in the company's finances at this time. Says "well-positioned for continued success." Comments made during the company's presentation regarding the CareFusion acquisition.
07:42 EDTCFNCareFusion volatility low into Becton Dickinson acquiring in $12.2B deal
CareFusion (CFN) overall option implied volatility of 21 compares to its 26-week average of 24 according to Track Data, suggesting decreasing price movement into Becton Dickinson (BDX) purchasing for $58 per share in cash and stock.
07:30 EDTCFNBecton Dickinson volatility flat into acquiring CareFusion in $12.2B deal
Becton Dickinson (BDX) overall option implied volatility of 15 is at its 26-week average according to Track Data, suggesting non-directional price movement into purchasing CareFusion (CFN) for $58 per share in cash and stock.
07:17 EDTCFNBecton Dickinson feels CareFusion deal will cut healthcare costs
Subscribe for More Information
06:20 EDTCFNBecton Dickinson upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded Becton Dickinson (BDX) to Neutral after the company announced an agreement to acquire CareFusion (CFN) for $12.2B.
05:43 EDTCFNBecton Dickinson and CareFusion to host joint conference call
Subscribe for More Information
1 | 2 | all recent CFN news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use